Mini Theta Burst TMS in MDD Patients

NACompletedINTERVENTIONAL
Enrollment

41

Participants

Timeline

Start Date

July 14, 2017

Primary Completion Date

June 30, 2020

Study Completion Date

June 30, 2021

Conditions
Major Depressive Disorder
Interventions
DEVICE

Transcranial Magnetic Stimulation

"Transcranial Magnetic Stimulation (TMS) is a non-invasive form of brain stimulation. TMS can influence activity in various brain regions, and it allows researchers to test or modify brain circuit communication. Repetitive TMS (rTMS) is FDA-approved for depression treatment.~TMS is administered over 5 study visits: an initial TMS/fMRI session, a 3-day TMS intervention regimen, and a post-intervention TMS/fMRI session. During TMS/fMRI sessions, participants receive single pulses of TMS pre/post a short round of Intermittent Theta Burst Stimulation (iTBS), a modified rTMS protocol. Throughout the 3-day intervention regimen, participants receive two full rounds of iTBS daily.~All study participants receive active TMS."

Trial Locations (1)

19104

University of Pennsylvania, Philadelphia

All Listed Sponsors
lead

University of Pennsylvania

OTHER

NCT04014959 - Mini Theta Burst TMS in MDD Patients | Biotech Hunter | Biotech Hunter